Michelle A. Wood‐Trageser, Drew Lesniak, Alessandro Gambella, Kayla Golnoski, Sandy Feng, John Bucuvalas, Alberto Sanchez‐Fueyo, A. Jake Demetris – 11 July 2022
Lukas Hartl, Thomas Reiberger, Michael Trauner – 11 July 2022
Fan Yang, Shi‐Tao Jiang, Xin Lu, Yiyao Xu, Yong‐Chang Zheng – 10 July 2022
Xiaowei Guo, Siyu Tan, Tixiao Wang, Renhui Sun, Shuangjie Li, Panpan Tian, Mengzhen Li, Yuzhen Wang, Yankun Zhang, Yuchuan Yan, Zhaoru Dong, Lunjie Yan, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Kazuya Yamagata, Lifen Gao, Chunhong Ma, Tao Li, Xiaohong Liang – 10 July 2022
Satender Pal Singh, Nitisha Mondia – 9 July 2022
Dongyao Wang, Huiwen Wu, Jianxin Yang, Min Li, Changquan Ling, Zelong Gao, Hongtao Lu, Hui Shen, Yuxiao Tang – 9 July 2022 – It is interesting that high iron is an independent inducer or cofactor of hepatocellular carcinoma (HCC) while the amount of iron is decreased in the liver tumor tissues. Due to the previous findings that iron deficiency promoted HCC metastasis, it is of significance to identify the underlying mechanism of iron deficiency in HCC. The tumor iron content and expressions of iron‐metabolic molecules were observed in the primary liver cancers of rats and mice.
Therese Bittermann, James D. Lewis, Cynthia Levy, David S. Goldberg – 9 July 2022
Hong Zhu, Bo Yang – 9 July 2022